Need help finding what you are looking for?
Contact Us
PUBLISHER: QYResearch | PRODUCT CODE: 1859992
PUBLISHER: QYResearch | PRODUCT CODE: 1859992
Mesalamine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
PUBLISHED:
PAGES: 113 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global market for Mesalamine was estimated to be worth US$ 190 million in 2024 and is forecast to a readjusted size of US$ 247 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Mesalamine cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Mesalamine also known as mesalazine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
In 2024, global Mesalamine sales reached approximately 5,417 tons, with an average global market price of around US$ 35.0 per kg.
The global prevalence of IBD is rising, particularly in developed regions like North America and Europe, and increasingly in developing nations such as China and India. This increase is largely attributed to changes in lifestyle, dietary habits, and environmental factors, which are contributing to the growing demand for mesalazine.
With ulcerative colitis being the primary indication for mesalazine, the growing number of patients with this condition is directly driving market demand.
Global key players of Mesalamine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalamine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.
This report aims to provide a comprehensive presentation of the global market for Mesalamine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Mesalamine by region & country, by Type, and by Application.
The Mesalamine market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalamine.
Market Segmentation
By Company
- PharmaZell
- Syntese A/S
- Cambrex Corporation
- Divis Laboratories
- Chemi SpA
- Ipca Laboratories
- Hangzhou Brother
- Lianyungang Fengheng Biopharm
- Lasa Loboratory
- Corden Pharma Bergamo
- Erregierre SpA
- CTX Lifescience
- Ishita Active Pharma Ingredients
- YC Biotech (Jiangsu)
Segment by Type
- Purity >= 97%
- Purity >= 98%
- Purity >= 99%
Segment by Application
- Tablets
- Capsules
- Granule
- Suppository
- Enema
- Others
By Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Mesalamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Mesalamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Mesalamine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
- 1.1 Mesalamine Product Introduction
- 1.2 Global Mesalamine Market Size Forecast
- 1.2.1 Global Mesalamine Sales Value (2020-2031)
- 1.2.2 Global Mesalamine Sales Volume (2020-2031)
- 1.2.3 Global Mesalamine Sales Price (2020-2031)
- 1.3 Mesalamine Market Trends & Drivers
- 1.3.1 Mesalamine Industry Trends
- 1.3.2 Mesalamine Market Drivers & Opportunity
- 1.3.3 Mesalamine Market Challenges
- 1.3.4 Mesalamine Market Restraints
- 1.4 Assumptions and Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Competitive Analysis by Company
- 2.1 Global Mesalamine Players Revenue Ranking (2024)
- 2.2 Global Mesalamine Revenue by Company (2020-2025)
- 2.3 Global Mesalamine Players Sales Volume Ranking (2024)
- 2.4 Global Mesalamine Sales Volume by Company Players (2020-2025)
- 2.5 Global Mesalamine Average Price by Company (2020-2025)
- 2.6 Key Manufacturers Mesalamine Manufacturing Base and Headquarters
- 2.7 Key Manufacturers Mesalamine Product Offered
- 2.8 Key Manufacturers Time to Begin Mass Production of Mesalamine
- 2.9 Mesalamine Market Competitive Analysis
- 2.9.1 Mesalamine Market Concentration Rate (2020-2025)
- 2.9.2 Global 5 and 10 Largest Manufacturers by Mesalamine Revenue in 2024
- 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalamine as of 2024)
- 2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
- 3.1 Introduction by Type
- 3.1.1 Purity >= 97%
- 3.1.2 Purity >= 98%
- 3.1.3 Purity >= 99%
- 3.2 Global Mesalamine Sales Value by Type
- 3.2.1 Global Mesalamine Sales Value by Type (2020 VS 2024 VS 2031)
- 3.2.2 Global Mesalamine Sales Value, by Type (2020-2031)
- 3.2.3 Global Mesalamine Sales Value, by Type (%) (2020-2031)
- 3.3 Global Mesalamine Sales Volume by Type
- 3.3.1 Global Mesalamine Sales Volume by Type (2020 VS 2024 VS 2031)
- 3.3.2 Global Mesalamine Sales Volume, by Type (2020-2031)
- 3.3.3 Global Mesalamine Sales Volume, by Type (%) (2020-2031)
- 3.4 Global Mesalamine Average Price by Type (2020-2031)
4 Segmentation by Application
- 4.1 Introduction by Application
- 4.1.1 Tablets
- 4.1.2 Capsules
- 4.1.3 Granule
- 4.1.4 Suppository
- 4.1.5 Enema
- 4.1.6 Others
- 4.2 Global Mesalamine Sales Value by Application
- 4.2.1 Global Mesalamine Sales Value by Application (2020 VS 2024 VS 2031)
- 4.2.2 Global Mesalamine Sales Value, by Application (2020-2031)
- 4.2.3 Global Mesalamine Sales Value, by Application (%) (2020-2031)
- 4.3 Global Mesalamine Sales Volume by Application
- 4.3.1 Global Mesalamine Sales Volume by Application (2020 VS 2024 VS 2031)
- 4.3.2 Global Mesalamine Sales Volume, by Application (2020-2031)
- 4.3.3 Global Mesalamine Sales Volume, by Application (%) (2020-2031)
- 4.4 Global Mesalamine Average Price by Application (2020-2031)
5 Segmentation by Region
- 5.1 Global Mesalamine Sales Value by Region
- 5.1.1 Global Mesalamine Sales Value by Region: 2020 VS 2024 VS 2031
- 5.1.2 Global Mesalamine Sales Value by Region (2020-2025)
- 5.1.3 Global Mesalamine Sales Value by Region (2026-2031)
- 5.1.4 Global Mesalamine Sales Value by Region (%), (2020-2031)
- 5.2 Global Mesalamine Sales Volume by Region
- 5.2.1 Global Mesalamine Sales Volume by Region: 2020 VS 2024 VS 2031
- 5.2.2 Global Mesalamine Sales Volume by Region (2020-2025)
- 5.2.3 Global Mesalamine Sales Volume by Region (2026-2031)
- 5.2.4 Global Mesalamine Sales Volume by Region (%), (2020-2031)
- 5.3 Global Mesalamine Average Price by Region (2020-2031)
- 5.4 North America
- 5.4.1 North America Mesalamine Sales Value, 2020-2031
- 5.4.2 North America Mesalamine Sales Value by Country (%), 2024 VS 2031
- 5.5 Europe
- 5.5.1 Europe Mesalamine Sales Value, 2020-2031
- 5.5.2 Europe Mesalamine Sales Value by Country (%), 2024 VS 2031
- 5.6 Asia Pacific
- 5.6.1 Asia Pacific Mesalamine Sales Value, 2020-2031
- 5.6.2 Asia Pacific Mesalamine Sales Value by Region (%), 2024 VS 2031
- 5.7 South America
- 5.7.1 South America Mesalamine Sales Value, 2020-2031
- 5.7.2 South America Mesalamine Sales Value by Country (%), 2024 VS 2031
- 5.8 Middle East & Africa
- 5.8.1 Middle East & Africa Mesalamine Sales Value, 2020-2031
- 5.8.2 Middle East & Africa Mesalamine Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
- 6.1 Key Countries/Regions Mesalamine Sales Value Growth Trends, 2020 VS 2024 VS 2031
- 6.2 Key Countries/Regions Mesalamine Sales Value and Sales Volume
- 6.2.1 Key Countries/Regions Mesalamine Sales Value, 2020-2031
- 6.2.2 Key Countries/Regions Mesalamine Sales Volume, 2020-2031
- 6.3 United States
- 6.3.1 United States Mesalamine Sales Value, 2020-2031
- 6.3.2 United States Mesalamine Sales Value by Type (%), 2024 VS 2031
- 6.3.3 United States Mesalamine Sales Value by Application, 2024 VS 2031
- 6.4 Europe
- 6.4.1 Europe Mesalamine Sales Value, 2020-2031
- 6.4.2 Europe Mesalamine Sales Value by Type (%), 2024 VS 2031
- 6.4.3 Europe Mesalamine Sales Value by Application, 2024 VS 2031
- 6.5 China
- 6.5.1 China Mesalamine Sales Value, 2020-2031
- 6.5.2 China Mesalamine Sales Value by Type (%), 2024 VS 2031
- 6.5.3 China Mesalamine Sales Value by Application, 2024 VS 2031
- 6.6 Japan
- 6.6.1 Japan Mesalamine Sales Value, 2020-2031
- 6.6.2 Japan Mesalamine Sales Value by Type (%), 2024 VS 2031
- 6.6.3 Japan Mesalamine Sales Value by Application, 2024 VS 2031
- 6.7 South Korea
- 6.7.1 South Korea Mesalamine Sales Value, 2020-2031
- 6.7.2 South Korea Mesalamine Sales Value by Type (%), 2024 VS 2031
- 6.7.3 South Korea Mesalamine Sales Value by Application, 2024 VS 2031
- 6.8 Southeast Asia
- 6.8.1 Southeast Asia Mesalamine Sales Value, 2020-2031
- 6.8.2 Southeast Asia Mesalamine Sales Value by Type (%), 2024 VS 2031
- 6.8.3 Southeast Asia Mesalamine Sales Value by Application, 2024 VS 2031
- 6.9 India
- 6.9.1 India Mesalamine Sales Value, 2020-2031
- 6.9.2 India Mesalamine Sales Value by Type (%), 2024 VS 2031
- 6.9.3 India Mesalamine Sales Value by Application, 2024 VS 2031
7 Company Profiles
- 7.1 PharmaZell
- 7.1.1 PharmaZell Company Information
- 7.1.2 PharmaZell Introduction and Business Overview
- 7.1.3 PharmaZell Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.1.4 PharmaZell Mesalamine Product Offerings
- 7.1.5 PharmaZell Recent Development
- 7.2 Syntese A/S
- 7.2.1 Syntese A/S Company Information
- 7.2.2 Syntese A/S Introduction and Business Overview
- 7.2.3 Syntese A/S Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.2.4 Syntese A/S Mesalamine Product Offerings
- 7.2.5 Syntese A/S Recent Development
- 7.3 Cambrex Corporation
- 7.3.1 Cambrex Corporation Company Information
- 7.3.2 Cambrex Corporation Introduction and Business Overview
- 7.3.3 Cambrex Corporation Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.3.4 Cambrex Corporation Mesalamine Product Offerings
- 7.3.5 Cambrex Corporation Recent Development
- 7.4 Divis Laboratories
- 7.4.1 Divis Laboratories Company Information
- 7.4.2 Divis Laboratories Introduction and Business Overview
- 7.4.3 Divis Laboratories Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.4.4 Divis Laboratories Mesalamine Product Offerings
- 7.4.5 Divis Laboratories Recent Development
- 7.5 Chemi SpA
- 7.5.1 Chemi SpA Company Information
- 7.5.2 Chemi SpA Introduction and Business Overview
- 7.5.3 Chemi SpA Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.5.4 Chemi SpA Mesalamine Product Offerings
- 7.5.5 Chemi SpA Recent Development
- 7.6 Ipca Laboratories
- 7.6.1 Ipca Laboratories Company Information
- 7.6.2 Ipca Laboratories Introduction and Business Overview
- 7.6.3 Ipca Laboratories Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.6.4 Ipca Laboratories Mesalamine Product Offerings
- 7.6.5 Ipca Laboratories Recent Development
- 7.7 Hangzhou Brother
- 7.7.1 Hangzhou Brother Company Information
- 7.7.2 Hangzhou Brother Introduction and Business Overview
- 7.7.3 Hangzhou Brother Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.7.4 Hangzhou Brother Mesalamine Product Offerings
- 7.7.5 Hangzhou Brother Recent Development
- 7.8 Lianyungang Fengheng Biopharm
- 7.8.1 Lianyungang Fengheng Biopharm Company Information
- 7.8.2 Lianyungang Fengheng Biopharm Introduction and Business Overview
- 7.8.3 Lianyungang Fengheng Biopharm Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.8.4 Lianyungang Fengheng Biopharm Mesalamine Product Offerings
- 7.8.5 Lianyungang Fengheng Biopharm Recent Development
- 7.9 Lasa Loboratory
- 7.9.1 Lasa Loboratory Company Information
- 7.9.2 Lasa Loboratory Introduction and Business Overview
- 7.9.3 Lasa Loboratory Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.9.4 Lasa Loboratory Mesalamine Product Offerings
- 7.9.5 Lasa Loboratory Recent Development
- 7.10 Corden Pharma Bergamo
- 7.10.1 Corden Pharma Bergamo Company Information
- 7.10.2 Corden Pharma Bergamo Introduction and Business Overview
- 7.10.3 Corden Pharma Bergamo Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.10.4 Corden Pharma Bergamo Mesalamine Product Offerings
- 7.10.5 Corden Pharma Bergamo Recent Development
- 7.11 Erregierre SpA
- 7.11.1 Erregierre SpA Company Information
- 7.11.2 Erregierre SpA Introduction and Business Overview
- 7.11.3 Erregierre SpA Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.11.4 Erregierre SpA Mesalamine Product Offerings
- 7.11.5 Erregierre SpA Recent Development
- 7.12 CTX Lifescience
- 7.12.1 CTX Lifescience Company Information
- 7.12.2 CTX Lifescience Introduction and Business Overview
- 7.12.3 CTX Lifescience Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.12.4 CTX Lifescience Mesalamine Product Offerings
- 7.12.5 CTX Lifescience Recent Development
- 7.13 Ishita Active Pharma Ingredients
- 7.13.1 Ishita Active Pharma Ingredients Company Information
- 7.13.2 Ishita Active Pharma Ingredients Introduction and Business Overview
- 7.13.3 Ishita Active Pharma Ingredients Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.13.4 Ishita Active Pharma Ingredients Mesalamine Product Offerings
- 7.13.5 Ishita Active Pharma Ingredients Recent Development
- 7.14 YC Biotech (Jiangsu)
- 7.14.1 YC Biotech (Jiangsu) Company Information
- 7.14.2 YC Biotech (Jiangsu) Introduction and Business Overview
- 7.14.3 YC Biotech (Jiangsu) Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.14.4 YC Biotech (Jiangsu) Mesalamine Product Offerings
- 7.14.5 YC Biotech (Jiangsu) Recent Development
8 Industry Chain Analysis
- 8.1 Mesalamine Industrial Chain
- 8.2 Mesalamine Upstream Analysis
- 8.2.1 Key Raw Materials
- 8.2.2 Raw Materials Key Suppliers
- 8.2.3 Manufacturing Cost Structure
- 8.3 Midstream Analysis
- 8.4 Downstream Analysis (Customers Analysis)
- 8.5 Sales Model and Sales Channels
- 8.5.1 Mesalamine Sales Model
- 8.5.2 Sales Channel
- 8.5.3 Mesalamine Distributors
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.1.1 Research Programs/Design
- 10.1.1.2 Market Size Estimation
- 10.1.1.3 Market Breakdown and Data Triangulation
- 10.1.2 Data Source
- 10.1.2.1 Secondary Sources
- 10.1.2.2 Primary Sources
- 10.1.1 Methodology/Research Approach
- 10.2 Author Details
- 10.3 Disclaimer
List of Tables
- Table 1. Mesalamine Market Trends
- Table 2. Mesalamine Market Drivers & Opportunity
- Table 3. Mesalamine Market Challenges
- Table 4. Mesalamine Market Restraints
- Table 5. Global Mesalamine Revenue by Company (2020-2025) & (US$ Million)
- Table 6. Global Mesalamine Revenue Market Share by Company (2020-2025)
- Table 7. Global Mesalamine Sales Volume by Company (2020-2025) & (Tons)
- Table 8. Global Mesalamine Sales Volume Market Share by Company (2020-2025)
- Table 9. Global Market Mesalamine Price by Company (2020-2025) & (US$/kg)
- Table 10. Key Manufacturers Mesalamine Manufacturing Base and Headquarters
- Table 11. Key Manufacturers Mesalamine Product Type
- Table 12. Key Manufacturers Time to Begin Mass Production of Mesalamine
- Table 13. Global Mesalamine Manufacturers Market Concentration Ratio (CR5 and HHI)
- Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalamine as of 2024)
- Table 15. Mergers & Acquisitions, Expansion Plans
- Table 16. Global Mesalamine Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
- Table 17. Global Mesalamine Sales Value by Type (2020-2025) & (US$ Million)
- Table 18. Global Mesalamine Sales Value by Type (2026-2031) & (US$ Million)
- Table 19. Global Mesalamine Sales Market Share in Value by Type (2020-2025)
- Table 20. Global Mesalamine Sales Market Share in Value by Type (2026-2031)
- Table 21. Global Mesalamine Sales Volume by Type: 2020 VS 2024 VS 2031 (Tons)
- Table 22. Global Mesalamine Sales Volume by Type (2020-2025) & (Tons)
- Table 23. Global Mesalamine Sales Volume by Type (2026-2031) & (Tons)
- Table 24. Global Mesalamine Sales Market Share in Volume by Type (2020-2025)
- Table 25. Global Mesalamine Sales Market Share in Volume by Type (2026-2031)
- Table 26. Global Mesalamine Price by Type (2020-2025) & (US$/kg)
- Table 27. Global Mesalamine Price by Type (2026-2031) & (US$/kg)
- Table 28. Global Mesalamine Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
- Table 29. Global Mesalamine Sales Value by Application (2020-2025) & (US$ Million)
- Table 30. Global Mesalamine Sales Value by Application (2026-2031) & (US$ Million)
- Table 31. Global Mesalamine Sales Market Share in Value by Application (2020-2025)
- Table 32. Global Mesalamine Sales Market Share in Value by Application (2026-2031)
- Table 33. Global Mesalamine Sales Volume by Application: 2020 VS 2024 VS 2031 (Tons)
- Table 34. Global Mesalamine Sales Volume by Application (2020-2025) & (Tons)
- Table 35. Global Mesalamine Sales Volume by Application (2026-2031) & (Tons)
- Table 36. Global Mesalamine Sales Market Share in Volume by Application (2020-2025)
- Table 37. Global Mesalamine Sales Market Share in Volume by Application (2026-2031)
- Table 38. Global Mesalamine Price by Application (2020-2025) & (US$/kg)
- Table 39. Global Mesalamine Price by Application (2026-2031) & (US$/kg)
- Table 40. Global Mesalamine Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
- Table 41. Global Mesalamine Sales Value by Region (2020-2025) & (US$ Million)
- Table 42. Global Mesalamine Sales Value by Region (2026-2031) & (US$ Million)
- Table 43. Global Mesalamine Sales Value by Region (2020-2025) & (%)
- Table 44. Global Mesalamine Sales Value by Region (2026-2031) & (%)
- Table 45. Global Mesalamine Sales Volume by Region (Tons): 2020 VS 2024 VS 2031
- Table 46. Global Mesalamine Sales Volume by Region (2020-2025) & (Tons)
- Table 47. Global Mesalamine Sales Volume by Region (2026-2031) & (Tons)
- Table 48. Global Mesalamine Sales Volume by Region (2020-2025) & (%)
- Table 49. Global Mesalamine Sales Volume by Region (2026-2031) & (%)
- Table 50. Global Mesalamine Average Price by Region (2020-2025) & (US$/kg)
- Table 51. Global Mesalamine Average Price by Region (2026-2031) & (US$/kg)
- Table 52. Key Countries/Regions Mesalamine Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
- Table 53. Key Countries/Regions Mesalamine Sales Value, (2020-2025) & (US$ Million)
- Table 54. Key Countries/Regions Mesalamine Sales Value, (2026-2031) & (US$ Million)
- Table 55. Key Countries/Regions Mesalamine Sales Volume, (2020-2025) & (Tons)
- Table 56. Key Countries/Regions Mesalamine Sales Volume, (2026-2031) & (Tons)
- Table 57. PharmaZell Company Information
- Table 58. PharmaZell Introduction and Business Overview
- Table 59. PharmaZell Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
- Table 60. PharmaZell Mesalamine Product Offerings
- Table 61. PharmaZell Recent Development
- Table 62. Syntese A/S Company Information
- Table 63. Syntese A/S Introduction and Business Overview
- Table 64. Syntese A/S Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
- Table 65. Syntese A/S Mesalamine Product Offerings
- Table 66. Syntese A/S Recent Development
- Table 67. Cambrex Corporation Company Information
- Table 68. Cambrex Corporation Introduction and Business Overview
- Table 69. Cambrex Corporation Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
- Table 70. Cambrex Corporation Mesalamine Product Offerings
- Table 71. Cambrex Corporation Recent Development
- Table 72. Divis Laboratories Company Information
- Table 73. Divis Laboratories Introduction and Business Overview
- Table 74. Divis Laboratories Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
- Table 75. Divis Laboratories Mesalamine Product Offerings
- Table 76. Divis Laboratories Recent Development
- Table 77. Chemi SpA Company Information
- Table 78. Chemi SpA Introduction and Business Overview
- Table 79. Chemi SpA Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
- Table 80. Chemi SpA Mesalamine Product Offerings
- Table 81. Chemi SpA Recent Development
- Table 82. Ipca Laboratories Company Information
- Table 83. Ipca Laboratories Introduction and Business Overview
- Table 84. Ipca Laboratories Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
- Table 85. Ipca Laboratories Mesalamine Product Offerings
- Table 86. Ipca Laboratories Recent Development
- Table 87. Hangzhou Brother Company Information
- Table 88. Hangzhou Brother Introduction and Business Overview
- Table 89. Hangzhou Brother Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
- Table 90. Hangzhou Brother Mesalamine Product Offerings
- Table 91. Hangzhou Brother Recent Development
- Table 92. Lianyungang Fengheng Biopharm Company Information
- Table 93. Lianyungang Fengheng Biopharm Introduction and Business Overview
- Table 94. Lianyungang Fengheng Biopharm Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
- Table 95. Lianyungang Fengheng Biopharm Mesalamine Product Offerings
- Table 96. Lianyungang Fengheng Biopharm Recent Development
- Table 97. Lasa Loboratory Company Information
- Table 98. Lasa Loboratory Introduction and Business Overview
- Table 99. Lasa Loboratory Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
- Table 100. Lasa Loboratory Mesalamine Product Offerings
- Table 101. Lasa Loboratory Recent Development
- Table 102. Corden Pharma Bergamo Company Information
- Table 103. Corden Pharma Bergamo Introduction and Business Overview
- Table 104. Corden Pharma Bergamo Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
- Table 105. Corden Pharma Bergamo Mesalamine Product Offerings
- Table 106. Corden Pharma Bergamo Recent Development
- Table 107. Erregierre SpA Company Information
- Table 108. Erregierre SpA Introduction and Business Overview
- Table 109. Erregierre SpA Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
- Table 110. Erregierre SpA Mesalamine Product Offerings
- Table 111. Erregierre SpA Recent Development
- Table 112. CTX Lifescience Company Information
- Table 113. CTX Lifescience Introduction and Business Overview
- Table 114. CTX Lifescience Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
- Table 115. CTX Lifescience Mesalamine Product Offerings
- Table 116. CTX Lifescience Recent Development
- Table 117. Ishita Active Pharma Ingredients Company Information
- Table 118. Ishita Active Pharma Ingredients Introduction and Business Overview
- Table 119. Ishita Active Pharma Ingredients Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
- Table 120. Ishita Active Pharma Ingredients Mesalamine Product Offerings
- Table 121. Ishita Active Pharma Ingredients Recent Development
- Table 122. YC Biotech (Jiangsu) Company Information
- Table 123. YC Biotech (Jiangsu) Introduction and Business Overview
- Table 124. YC Biotech (Jiangsu) Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
- Table 125. YC Biotech (Jiangsu) Mesalamine Product Offerings
- Table 126. YC Biotech (Jiangsu) Recent Development
- Table 127. Key Raw Materials Lists
- Table 128. Raw Materials Key Suppliers Lists
- Table 129. Mesalamine Downstream Customers
- Table 130. Mesalamine Distributors List
- Table 131. Research Programs/Design for This Report
- Table 132. Key Data Information from Secondary Sources
- Table 133. Key Data Information from Primary Sources
List of Figures
- Figure 1. Mesalamine Product Picture
- Figure 2. Global Mesalamine Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
- Figure 3. Global Mesalamine Sales Value (2020-2031) & (US$ Million)
- Figure 4. Global Mesalamine Sales Volume (2020-2031) & (Tons)
- Figure 5. Global Mesalamine Sales Price (2020-2031) & (US$/kg)
- Figure 6. Mesalamine Report Years Considered
- Figure 7. Global Mesalamine Players Revenue Ranking (2024) & (US$ Million)
- Figure 8. Global Mesalamine Players Sales Volume Ranking (2024) & (Tons)
- Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Mesalamine Revenue in 2024
- Figure 10. Mesalamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
- Figure 11. Purity >= 97% Picture
- Figure 12. Purity >= 98% Picture
- Figure 13. Purity >= 99% Picture
- Figure 14. Global Mesalamine Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
- Figure 15. Global Mesalamine Sales Value Market Share by Type, 2024 & 2031
- Figure 16. Global Mesalamine Sales Volume by Type (2020 VS 2024 VS 2031) & (Tons)
- Figure 17. Global Mesalamine Sales Volume Market Share by Type, 2024 & 2031
- Figure 18. Global Mesalamine Price by Type (2020-2031) & (US$/kg)
- Figure 19. Product Picture of Tablets
- Figure 20. Product Picture of Capsules
- Figure 21. Product Picture of Granule
- Figure 22. Product Picture of Suppository
- Figure 23. Product Picture of Enema
- Figure 24. Product Picture of Others
- Figure 25. Global Mesalamine Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
- Figure 26. Global Mesalamine Sales Value Market Share by Application, 2024 & 2031
- Figure 27. Global Mesalamine Sales Volume by Application (2020 VS 2024 VS 2031) & (Tons)
- Figure 28. Global Mesalamine Sales Volume Market Share by Application, 2024 & 2031
- Figure 29. Global Mesalamine Price by Application (2020-2031) & (US$/kg)
- Figure 30. North America Mesalamine Sales Value (2020-2031) & (US$ Million)
- Figure 31. North America Mesalamine Sales Value by Country (%), 2024 VS 2031
- Figure 32. Europe Mesalamine Sales Value, (2020-2031) & (US$ Million)
- Figure 33. Europe Mesalamine Sales Value by Country (%), 2024 VS 2031
- Figure 34. Asia Pacific Mesalamine Sales Value, (2020-2031) & (US$ Million)
- Figure 35. Asia Pacific Mesalamine Sales Value by Region (%), 2024 VS 2031
- Figure 36. South America Mesalamine Sales Value, (2020-2031) & (US$ Million)
- Figure 37. South America Mesalamine Sales Value by Country (%), 2024 VS 2031
- Figure 38. Middle East & Africa Mesalamine Sales Value, (2020-2031) & (US$ Million)
- Figure 39. Middle East & Africa Mesalamine Sales Value by Country (%), 2024 VS 2031
- Figure 40. Key Countries/Regions Mesalamine Sales Value (%), (2020-2031)
- Figure 41. Key Countries/Regions Mesalamine Sales Volume (%), (2020-2031)
- Figure 42. United States Mesalamine Sales Value, (2020-2031) & (US$ Million)
- Figure 43. United States Mesalamine Sales Value by Type (%), 2024 VS 2031
- Figure 44. United States Mesalamine Sales Value by Application (%), 2024 VS 2031
- Figure 45. Europe Mesalamine Sales Value, (2020-2031) & (US$ Million)
- Figure 46. Europe Mesalamine Sales Value by Type (%), 2024 VS 2031
- Figure 47. Europe Mesalamine Sales Value by Application (%), 2024 VS 2031
- Figure 48. China Mesalamine Sales Value, (2020-2031) & (US$ Million)
- Figure 49. China Mesalamine Sales Value by Type (%), 2024 VS 2031
- Figure 50. China Mesalamine Sales Value by Application (%), 2024 VS 2031
- Figure 51. Japan Mesalamine Sales Value, (2020-2031) & (US$ Million)
- Figure 52. Japan Mesalamine Sales Value by Type (%), 2024 VS 2031
- Figure 53. Japan Mesalamine Sales Value by Application (%), 2024 VS 2031
- Figure 54. South Korea Mesalamine Sales Value, (2020-2031) & (US$ Million)
- Figure 55. South Korea Mesalamine Sales Value by Type (%), 2024 VS 2031
- Figure 56. South Korea Mesalamine Sales Value by Application (%), 2024 VS 2031
- Figure 57. Southeast Asia Mesalamine Sales Value, (2020-2031) & (US$ Million)
- Figure 58. Southeast Asia Mesalamine Sales Value by Type (%), 2024 VS 2031
- Figure 59. Southeast Asia Mesalamine Sales Value by Application (%), 2024 VS 2031
- Figure 60. India Mesalamine Sales Value, (2020-2031) & (US$ Million)
- Figure 61. India Mesalamine Sales Value by Type (%), 2024 VS 2031
- Figure 62. India Mesalamine Sales Value by Application (%), 2024 VS 2031
- Figure 63. Mesalamine Industrial Chain
- Figure 64. Mesalamine Manufacturing Cost Structure
- Figure 65. Channels of Distribution (Direct Sales, and Distribution)
- Figure 66. Bottom-up and Top-down Approaches for This Report
- Figure 67. Data Triangulation
- Figure 68. Key Executives Interviewed
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.